Cirrhotic Cardiomyopathy
Key result
Cirrhotic cardiomyopathy affects up to ~50% of patients undergoing liver transplantation.
Population
Patients with liver cirrhosis (cirrhotic cardiomyopathy)
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Cirrhotic cardiomyopathy is a significant clinical syndrome, with up to 50% of liver transplant patients showing cardiac dysfunction and 7-21% of post-transplant deaths resulting from heart failure.
Key Points
- The aim is to evaluate the pathophysiology and clinical implications associated with cirrhotic cardiomyopathy.
- Critical review of existing literature
- Analysis of cardiac function in cirrhotic patients
- Assessment of cardiac dysfunction in liver transplant cohorts.
- Up to 50% of cirrhotic patients show cardiac dysfunction pre-liver transplantation.
- 7% to 21% of post-transplant deaths are due to overt heart failure.
- Identified abnormal cardiac response to stress in cirrhosis patients.
Structured PICO
P
Population
Patients with liver cirrhosis (cirrhotic cardiomyopathy)
Cirrhotic cardiomyopathy is a significant clinical syndrome, with up to 50% of liver transplant patients showing cardiac dysfunction and 7-21% of post-transplant deaths resulting from heart failure.
Cite This Study
Zardi et al. (2010) conducted a review in Cirrhotic cardiomyopathy. Cirrhotic cardiomyopathy is a clinical syndrome in liver cirrhosis, with up to 50% of patients undergoing liver transplantation showing signs of cardiac dysfunction.